CMH Wealth Management LLC decreased its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 11.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,064 shares of the company’s stock after selling 398 shares during the quarter. CMH Wealth Management LLC’s holdings in Procter & Gamble were worth $514,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in PG. Concurrent Investment Advisors LLC boosted its position in Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after buying an additional 4,035 shares during the period. Copley Financial Group Inc. acquired a new stake in shares of Procter & Gamble in the third quarter valued at $668,000. Fortem Financial Group LLC purchased a new position in Procter & Gamble in the fourth quarter valued at $569,000. Nordea Investment Management AB grew its stake in Procter & Gamble by 7.5% during the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock worth $484,583,000 after purchasing an additional 201,695 shares in the last quarter. Finally, Synovus Financial Corp increased its holdings in Procter & Gamble by 3.4% during the 3rd quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock worth $32,065,000 after purchasing an additional 6,077 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Stock Performance
Shares of PG stock opened at $161.77 on Wednesday. The stock’s 50-day moving average price is $169.09 and its 200 day moving average price is $169.44. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $380.96 billion, a PE ratio of 27.89, a price-to-earnings-growth ratio of 3.63 and a beta of 0.45. The Procter & Gamble Company has a 52-week low of $146.28 and a 52-week high of $180.43.
Procter & Gamble Dividend Announcement
Insider Buying and Selling
In related news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now owns 11,595 shares in the company, valued at $2,002,804.35. This trade represents a 52.47 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now owns 39,977 shares in the company, valued at $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 73,447 shares of company stock valued at $12,978,820 over the last three months. 0.18% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on the company. Morgan Stanley boosted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Wells Fargo & Company decreased their price objective on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Barclays dropped their target price on Procter & Gamble from $163.00 to $155.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Finally, DA Davidson reaffirmed a “buy” rating and set a $209.00 price objective on shares of Procter & Gamble in a research report on Friday, December 27th. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $179.65.
Check Out Our Latest Research Report on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- SAP’s Strong Momentum: A Bullish Setup for Investors
- 3 Stocks to Consider Buying in October
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.